Evaluation of 3′,4′-cyclopropyl monomers for oligonucleotide therapeutic applications

vitro snake venom phosphodiesterase (SVPD) assays demonstrated that Cp-modified ASOs exhibit significantly enhanced nuclease resistance over the unmodified parent sequence, sometimes providing near-complete protection. This differential effect on stability and potency across the different oligonucleotide lengths and modalities warrants further investigation to fully delineate the mechanism of action of these modifications and to further optimize their application in therapeutic oligonucleotide design. Here, based on these results, we propose Cp monomers as a novel class of molecules for oligonucleotide therapeutic applications.

Authors

Institutions

Publication Details

Journal
Organic & Biomolecular Chemistry
Published
2026-11-18
DOI
https://doi.org/10.1039/d6ob01291d
Primary Topic
DNA and Nucleic Acid Chemistry
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of 3′,4′-cyclopropyl monomers for oligonucleotide therapeutic applications

Santhosh Kumar Thatikonda, Jinsen Chen, Steven Chin, Seetha S. Krishnamoorthy et al.
1 links
Organic & Biomolecular Chemistry
DNA and Nucleic Acid Chemistry
article

Evaluation of 3′,4′-cyclopropyl monomers for oligonucleotide therapeutic applications

Santhosh Kumar Thatikonda, Jinsen Chen, Steven Chin, Seetha S. Krishnamoorthy, Molly S. Blevins, Aditi Dubey, Yi‐Ju Tseng, Yongfeng Yang, Sumit Mahajan, Han Nguyen, Xiaoshuai Fan, Jeff Cheng-Wei Lin, Andrew Watkins, Kayon Colao
article en

Abstract

vitro snake venom phosphodiesterase (SVPD) assays demonstrated that Cp-modified ASOs exhibit significantly enhanced nuclease resistance over the unmodified parent sequence, sometimes providing near-complete protection. This differential effect on stability and potency across the different oligonucleotide lengths and modalities warrants further investigation to fully delineate the mechanism of action of these modifications and to further optimize their application in therapeutic oligonucleotide design. Here, based on these results, we propose Cp monomers as a novel class of molecules for oligonucleotide therapeutic applications.

Organic & Biomolecular ChemistryVol. 24(44)
Genentech (US)
DNA and Nucleic Acid Chemistry
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon